Trial Outcomes & Findings for The Role of Ambulatory Oxygen in Improving the Effectiveness of Pulmonary Rehabilitation for COPD Patients (NCT NCT02707770)

NCT ID: NCT02707770

Last Updated: 2021-03-30

Results Overview

6 Minute Walk Test (6MWT)- Distance in meters

Recruitment status

TERMINATED

Study phase

NA

Target enrollment

20 participants

Primary outcome timeframe

0, 8weeks

Results posted on

2021-03-30

Participant Flow

Participant milestones

Participant milestones
Measure
Ambulatory Oxygen
Patient will use ambulatory oxygen during pulmonary rehabilitation programme (flow rate determined at the initial assessment to a maximum flow rate of 6 litres per minute) Pulmonary Rehabilitation
Room Air
Patient will breath on room air during pulmonary rehabilitation programme Pulmonary Rehabilitation
Overall Study
STARTED
10
10
Overall Study
COMPLETED
9
10
Overall Study
NOT COMPLETED
1
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Ambulatory Oxygen
n=9 Participants
Patient will use ambulatory oxygen during pulmonary rehabilitation programme (flow rate determined at the initial assessment to a maximum flow rate of 6 litres per minute)
Room Air
n=10 Participants
Patient will breath on room air during pulmonary rehabilitation programme
Total
n=19 Participants
Total of all reporting groups
Age, Continuous
73 years
n=9 Participants
72 years
n=10 Participants
72.5 years
n=19 Participants
Sex: Female, Male
Female
2 Participants
n=9 Participants
6 Participants
n=10 Participants
8 Participants
n=19 Participants
Sex: Female, Male
Male
7 Participants
n=9 Participants
4 Participants
n=10 Participants
11 Participants
n=19 Participants
Race and Ethnicity Not Collected
0 Participants
Race and Ethnicity were not collected from any participant.
Region of Enrollment
United Kingdom
9 participants
n=9 Participants
10 participants
n=10 Participants
19 participants
n=19 Participants

PRIMARY outcome

Timeframe: 0, 8weeks

6 Minute Walk Test (6MWT)- Distance in meters

Outcome measures

Outcome measures
Measure
Ambulatory Oxygen
n=9 Participants
Patient will use ambulatory oxygen during pulmonary rehabilitation programme (flow rate determined at the initial assessment to a maximum flow rate of 6 litres per minute) Pulmonary Rehabilitation
Room Air
n=10 Participants
Patient will breath on room air during pulmonary rehabilitation programme Pulmonary Rehabilitation
Change in Functional Exercise Capacity
Baseline -0
332 meters
Interval 170.0 to 430.0
335 meters
Interval 140.0 to 500.0
Change in Functional Exercise Capacity
Post PR - 8weeks
346 meters
Interval 200.0 to 430.0
340 meters
Interval 140.0 to 510.0

SECONDARY outcome

Timeframe: 0,8weeks

Chronic Respiratory Questionnaire(CRQ)- Number of Participants achieving minimal clinically important difference (MCID) in CRQ compared between baseline and follow up assessment.

Outcome measures

Outcome measures
Measure
Ambulatory Oxygen
n=9 Participants
Patient will use ambulatory oxygen during pulmonary rehabilitation programme (flow rate determined at the initial assessment to a maximum flow rate of 6 litres per minute) Pulmonary Rehabilitation
Room Air
n=10 Participants
Patient will breath on room air during pulmonary rehabilitation programme Pulmonary Rehabilitation
Number of Participants Reporting a Change in the Quality of Life
3 participants
2 participants

SECONDARY outcome

Timeframe: 0,8weeks

Hospital anxiety and depression score- Anxiety component (HADS-A)-Numbers of participants achieving Minimal clinically important difference in HADS-A compared between baseline and follow up assessment.

Outcome measures

Outcome measures
Measure
Ambulatory Oxygen
n=9 Participants
Patient will use ambulatory oxygen during pulmonary rehabilitation programme (flow rate determined at the initial assessment to a maximum flow rate of 6 litres per minute) Pulmonary Rehabilitation
Room Air
n=10 Participants
Patient will breath on room air during pulmonary rehabilitation programme Pulmonary Rehabilitation
Number of Participants Reporting a Change in Anxiety Score
4 participants
3 participants

SECONDARY outcome

Timeframe: 0,8weeks

Hospital anxiety and depression score- Depression component (HADS-D)-Numbers of participants achieving Minimal clinically important difference in HADS-D compared between baseline and follow up assessment.

Outcome measures

Outcome measures
Measure
Ambulatory Oxygen
n=9 Participants
Patient will use ambulatory oxygen during pulmonary rehabilitation programme (flow rate determined at the initial assessment to a maximum flow rate of 6 litres per minute) Pulmonary Rehabilitation
Room Air
n=10 Participants
Patient will breath on room air during pulmonary rehabilitation programme Pulmonary Rehabilitation
Number of Participants Reporting Change in Depression Score
2 participants
2 participants

SECONDARY outcome

Timeframe: 0,8weeks

Chronic Obstructive Pulmonary diseases Assessment Test (CAT score)-Numbers of participants achieving Minimal clinically important difference in CAT score compared between baseline and follow up assessment.

Outcome measures

Outcome measures
Measure
Ambulatory Oxygen
n=9 Participants
Patient will use ambulatory oxygen during pulmonary rehabilitation programme (flow rate determined at the initial assessment to a maximum flow rate of 6 litres per minute) Pulmonary Rehabilitation
Room Air
n=10 Participants
Patient will breath on room air during pulmonary rehabilitation programme Pulmonary Rehabilitation
Number of Participants Reporting Change in Chronic Obstructive Pulmonary Diseases Assessment Test (CAT)
5 participants
3 participants

SECONDARY outcome

Timeframe: 8 weeks

Population: Due to technical problems identified with accuracy of device, this outcome measure was excluded from study

Pedometer- Number of step counts

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 0,8 weeks

Handheld Muscle testing- Number of participants achieving Minimal clinical important difference in quadriceps muscle strength compared between baseline and follow up assessment

Outcome measures

Outcome measures
Measure
Ambulatory Oxygen
n=8 Participants
Patient will use ambulatory oxygen during pulmonary rehabilitation programme (flow rate determined at the initial assessment to a maximum flow rate of 6 litres per minute) Pulmonary Rehabilitation
Room Air
n=6 Participants
Patient will breath on room air during pulmonary rehabilitation programme Pulmonary Rehabilitation
Number of Participants With Change in Quadriceps Muscle Strength
0 Participants
0 Participants

Adverse Events

Ambulatory Oxygen

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Room Air

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

vijay padmanaban

Imperial college healthcare NHS trust

Phone: 02033122349

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place